The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Cancer-associated lysosomal changes: friends or foes?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
The anti-angiogenic activity of NSITC, a specific cathepsin L inhibitor.
Rebbaa, A., Chu, F., Sudha, T., Gallati, C., Dier, U., Dyskin, E., Yalçın, M., Bianchini, C., Shaker, O. G., & Mousa, S. A. (2009) · PubMed · Cited by 28
RetractedMembrane lipids: where they are and how they behave
van Meer, G., Voelker, D. R., & Feigenson, G. W. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2330 · Cited by 7,157
TFEB Links Autophagy to Lysosomal Biogenesis
Settembre, C., Di Malta, C., Polito, V. A., Arencibia, M. G., Vetrini, F., Erdin, S., Erdin, S. U., Huynh, T., Medina, D., Colella, P., et al. (2011) · Science · doi:10.1126/science.1204592 · Cited by 3,365
Principles of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333
Functions of Cell Surface Heparan Sulfate Proteoglycans
Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., & Zako, M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.729 · Cited by 2,688
A Gene Network Regulating Lysosomal Biogenesis and Function
Sardiello, M., Palmieri, M., di Ronza, A., Medina, D. L., Valenza, M., Gennarino, V. A., Di Malta, C., Donaudy, F., Embrione, V., Polishchuk, R. S., et al. (2009) · Science · doi:10.1126/science.1174447 · Cited by 2,543
Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function
Saftig, P., & Klumperman, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2745 · Cited by 1,648
Lysosomal membrane permeabilization in cell death
Boya, P., & Kroemer, G. (2008) · Oncogene · doi:10.1038/onc.2008.310 · Cited by 1,426
Lysosomes and autophagy in cell death control
Kroemer, G., & Jäättelä, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1738 · Cited by 1,285
Self-citationmultifunctional enzymes in cancer
Mohamed, M. M., & Sloane, B. F. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1949 · Cited by 1,265
Lysosomal acidification mechanisms
Mindell, J. A. (2012) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142317 · Cited by 1,258
Biologically active sphingolipids in cancer pathogenesis and treatment
Ogretmen, B., & Hannun, Y. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1411 · Cited by 1,213
Pycnodysostosis, a Lysosomal Disease Caused by Cathepsin K Deficiency
Gelb, B. D., Shi, G.-P., Chapman, H. A., & Desnick, R. J. (1996) · Science · doi:10.1126/science.273.5279.1236 · Cited by 1,029
A Receptor for the Selective Uptake and Degradation of Proteins by Lysosomes
Cuervo, A. M., & Dice, J. F. (1996) · Science · doi:10.1126/science.273.5274.501 · Cited by 979
Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy
Eskelinen, E.-L. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2006.08.005 · Cited by 955
Folkman, J., Klagsbrun, M., Sasse, J., Wadzinski, M., Ingber, D. E., & Vlodavsky, I. (1988) · PubMed Central · Cited by 875
Braulke, T., & Bonifacino, J. S. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.10.016 · Cited by 811
NEW EMBO MEMBERS' REVIEW: Lysosomal cysteine proteases: facts and opportunities
Turk, V. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4629 · Cited by 756
Gocheva, V., Wang, H.-W., Gadea, B. B., Shree, T., Hunter, K. E., Garfall, A. L., Berman, T., & Joyce, J. A. (2010) · Genes & Development · doi:10.1101/gad.1874010 · Cited by 740
At the acidic edge: emerging functions for lysosomal membrane proteins
Eskelinen, E.-L., Tanaka, Y., & Saftig, P. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00005-9 · Cited by 660
Joyce, J. A., Baruch, A., Chehade, K., Meyer-Morse, N., Giraudo, E., Tsai, F.-Y., Greenbaum, D. C., Hager, J. H., Bogyo, M., & Hanahan, D. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00111-4 · Cited by 645
The V-type H+ ATPase: molecular structure and function,physiological roles and regulation
Beyenbach, K. W., & Wieczorek, H. (2006) · Journal of Experimental Biology · doi:10.1242/jeb.02014 · Cited by 627
Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis
Vlodavsky, I., & Friedmann, Y. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13662 · Cited by 618
Cathepsin D--many functions of one aspartic protease
Benes, P., Vetvicka, V., & Fusek, M. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.02.008 · Cited by 572
Distinct roles for cysteine cathepsin genes in multistage tumorigenesis
Gocheva, V., Zeng, W., Ke, D., Klimstra, D., Reinheckel, T., Peters, C., Hanahan, D., & Joyce, J. A. (2006) · Genes & Development · doi:10.1101/gad.1407406 · Cited by 570
Proteolytic networks in cancer
Mason, S. D., & Joyce, J. A. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.12.002 · Cited by 552
Heat Shock Protein 70 Promotes Cell Survival by Inhibiting Lysosomal Membrane Permeabilization
Nylandsted, J., Gyrd-Hansen, M., Danielewicz, A., Fehrenbacher, N., Lademann, U., Høyer-Hansen, M., Weber, E., Multhoff, G., Rohde, M., & Jäättelä, M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040531 · Cited by 545
LIMP-2 Is a Receptor for Lysosomal Mannose-6-Phosphate-Independent Targeting of β-Glucocerebrosidase
Reczek, D., Schwake, M., Schröder, J., Hughes, H., Blanz, J., Jin, X., Brondyk, W., Van Patten, S., Edmunds, T., & Saftig, P. (2007) · Cell · doi:10.1016/j.cell.2007.10.018 · Cited by 542
Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis
Ilan, N., Elkin, M., & Vlodavsky, I. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.06.004 · Cited by 524
Hsp70 stabilizes lysosomes and reverts Niemann–Pick disease-associated lysosomal pathology
Kirkegaard, T., Roth, A. G., Petersen, N. H. T., Mahalka, A. K., Olsen, O. D., Moilanen, I., Zylicz, A., Knudsen, J., Sandhoff, K., Arenz, C., et al. (2010) · Nature · doi:10.1038/nature08710 · Cited by 519
Self-citationSynthetic lethal screen identification of chemosensitizer loci in cancer cells
Whitehurst, A. W., Bodemann, B. O., Cardenas, J., Ferguson, D., Girard, L., Peyton, M., Minna, J. D., Michnoff, C., Hao, W., Roth, M. G., et al. (2007) · Nature · doi:10.1038/nature05697 · Cited by 474
Heparanase: a key enzyme involved in cell invasion
Parish, C. R., Freeman, C., & Hulett, M. D. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00017-8 · Cited by 466
Regulation of TFEB and V-ATPases by mTORC1
Peña-Llopis, S., Vega-Rubin-de-Celis, S., Schwartz, J. C., Wolff, N. C., Tran, T. A. T., Zou, L., Xie, X.-J., Corey, D. R., & Brugarolas, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.257 · Cited by 462
Möbius, W., Van Donselaar, E., Ohno‐Iwashita, Y., Shimada, Y., Heijnen, H. F. G., Slot, J. W., & Geuze, H. J. (2003) · Traffic · doi:10.1034/j.1600-0854.2003.00072.x · Cited by 453
Emerging Roles of Cysteine Cathepsins in Disease and their Potential as Drug Targets
Vasiljeva, O., Reinheckel, T., Peters, C., Turk, D., Turk, V., & Turk, B. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780162962 · Cited by 450
Cysteine Cathepsins and the Cutting Edge of Cancer Invasion
Gocheva, V., & Joyce, J. A. (2007) · Cell Cycle · doi:10.4161/cc.6.1.3669 · Cited by 437
Effect of Proton Pump Inhibitor Pretreatment on Resistance of Solid Tumors to Cytotoxic Drugs
Luciani, F., Spada, M., De Milito, A., Molinari, A., Rivoltini, L., Montinaro, A., Marra, M., Lugini, L., Logozzi, M., Lozupone, F., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh305 · Cited by 435
Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues
Buck, M. R., Karustis, D. G., Day, N. A., Honn, K. V., & Sloane, B. F. (1992) · Biochemical Journal · doi:10.1042/bj2820273 · Cited by 422
Molecular mechanisms of endolysosomal Ca2+ signalling in health and disease
Morgan, A. J., Platt, F. M., Lloyd-Evans, E., & Galione, A. (2011) · Biochemical Journal · doi:10.1042/bj20110949 · Cited by 399
Petersen, C. M., Nielsen, M. S., Nykjær, A., Jacobsen, L., Tommerup, N., Rasmussen, H. H., RØigaard, H., Gliemann, J., Madsen, P., & Moestrup, S. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3599 · Cited by 399
Lysosomal involvement in cell death and cancer
Kirkegaard, T., & Jäättelä, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.09.008 · Cited by 395
Self-citationRegulation and Isoform Function of the V-ATPases
Toei, M., Saum, R., & Forgac, M. (2010) · Biochemistry · doi:10.1021/bi100397s · Cited by 391
MEROPS: the peptidase database
Rawlings, N. D. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh071 · Cited by 376
Vasiljeva, O., Papazoglou, A., Krüger, A., Brodoefel, H., Korovin, M., Deussing, J., Augustin, N., Nielsen, B. S., Almholt, K., Bogyo, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4463 · Cited by 375
Goulet, B., Baruch, A., Moon, N.-S., Poirier, M., Sansregret, L. L., Erickson, A., Bogyo, M., & Nepveu, A. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00209-6 · Cited by 369
Cathepsin D targeted by acid sphingomyelinase-derived ceramide
Heinrich, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5252 · Cited by 365
Cathepsin L Proteolytically Processes Histone H3 During Mouse Embryonic Stem Cell Differentiation
Duncan, E. M., Muratore-Schroeder, T. L., Cook, R. G., Garcia, B. A., Shabanowitz, J., Hunt, D. F., & Allis, C. D. (2008) · Cell · doi:10.1016/j.cell.2008.09.055 · Cited by 364
Kornhuber, J., Tripal, P., Reichel, M., Mühle, C., Rhein, C., Muehlbacher, M., Groemer, T. W., & Gulbins, E. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000315101 · Cited by 354
Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis
Liaudet-Coopman, E., Beaujouin, M., Derocq, D., Garcia, M., Glondu-Lassis, M., Laurent-Matha, V., Prébois, C., Rochefort, H., & Vignon, F. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.06.007 · Cited by 351
Kobayashi, H., Schmitt, M., Goretzki, L., Chucholowski, N., Calvete, J., Kramer, M., Günzler, W. A., Jänicke, F., & Graeff, H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67767-7 · Cited by 343
Sennoune, S. R., Bakunts, K., Martínez, G. M., Chua-Tuan, J. L., Kebir, Y., Attaya, M. N., & Martínez-Zaguilán, R. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00407.2003 · Cited by 333
Bonten, E., van der Spoel, A., Fornerod, M., Grosveld, G., & d'Azzo, A. (1996) · Genes & Development · doi:10.1101/gad.10.24.3156 · Cited by 313
Cysteine cathepsin proteases as pharmacological targets in cancer
Palermo, C., & Joyce, J. A. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.10.011 · Cited by 310
Saitoh, O., Wang, W. C., Lotan, R., & Fukuda, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42823-2 · Cited by 308
Cysteine cathepsins in human cancer
Jedeszko, C., & Sloane, B. F. (2004) · Biological Chemistry · doi:10.1515/bc.2004.132 · Cited by 307
Targeting SphK1 as a New Strategy against Cancer
Shida, D., Takabe, K., Kapitonov, D., Milstien, S., & Spiegel, S. (2008) · Current Drug Targets · doi:10.2174/138945008785132402 · Cited by 307
Cathepsin S Controls Angiogenesis and Tumor Growth via Matrix-derived Angiogenic Factors
Wang, B., Sun, J., Kitamoto, S., Yang, M., Grubb, A., Chapman, H. A., Kalluri, R., & Shi, G.-P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509134200 · Cited by 290
Roles and regulation of secretory and lysosomal acid sphingomyelinase
Jenkins, R. W., Canals, D., & Hannun, Y. A. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.01.026 · Cited by 278
Lysosomal degradation of membrane lipids
Kolter, T., & Sandhoff, K. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.10.021 · Cited by 275
De Milito, A., Canese, R., Marino, M. L., Borghi, M., Iero, M., Villa, A., Venturi, G., Lozupone, F., Iessi, E., Logozzi, M., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25009 · Cited by 274
TFEB regulates autophagy: An integrated coordination of cellular degradation and recycling processes
Settembre, C., & Ballabio, A. (2011) · Autophagy · doi:10.4161/auto.7.11.17166 · Cited by 251
Ostenfeld, M. S., Fehrenbacher, N., Høyer-Hansen, M., Thomsen, C., Farkas, T., & Jäättelä, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0269 · Cited by 248
Roles of Bioactive Sphingolipids in Cancer Biology and Therapeutics
Saddoughi, S. A., Song, P., & Ogretmen, B. (2008) · Subcellular Biochemistry · doi:10.1007/978-1-4020-8831-5_16 · Cited by 243
Fehrenbacher, N., Bastholm, L., Kirkegaard-Sørensen, T., Rafn, B., Bøttzauw, T., Nielsen, C., Weber, E., Shirasawa, S., Kallunki, T., & Jäättelä, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0463 · Cited by 242
Self-citationRole of the Endocytic Machinery in the Sorting of Lysosome-associated Membrane Proteins
Janvier, K., & Bonifacino, J. S. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-03-0213 · Cited by 227
The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma.
Littlewood-Evans, A., Bilbe, G., Bowler, W. B., Farley, D. R., Wlodarski, B., Kokubo, T., Inaoka, T., Sloane, J. P., Evans, D. B., & Gallagher, J. A. (1997) · PubMed · Cited by 224
Inhibitors of V-ATPases: old and new players
Huss, M., & Wieczorek, H. (2009) · Journal of Experimental Biology · doi:10.1242/jeb.024067 · Cited by 209
Hinton, A., Sennoune, S. R., Bond, S., Fang, M., Reuveni, M., Sahagian, G. G., Jay, D., Martinez-Zaguilan, R., & Forgac, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901201200 · Cited by 206
A Cathepsin K Inhibitor Reduces Breast Cancer–Induced Osteolysis and Skeletal Tumor Burden
Le Gall, C., Bellahcène, A., Bonnelye, E., Gasser, J. A., Castronovo, V., Green, J., Zimmermann, J., & Clézardin, P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3940 · Cited by 204
Expression of Heparanase in Normal, Dysplastic, and Neoplastic Human Colonic Mucosa and Stroma
Friedmann, Y., Vlodavsky, I., Aingorn, H., Aviv, A., Peretz, T., Pecker, I., & Pappo, O. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64632-9 · Cited by 202
Cathepsin B Inhibition Limits Bone Metastasis in Breast Cancer
Withana, N. P., Blum, G., Sameni, M., Slaney, C., Anbalagan, A., Olive, M. B., Bidwell, B. N., Edgington, L., Wang, L., Moin, K., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2759 · Cited by 202
V-ATPase inhibitors and implication in cancer treatment
Pérez-Sayáns, M., Somoza-Martín, J. M., Barros-Angueira, F., Rey, J. M. G., & García-García, A. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.08.003 · Cited by 198
Intra-endosomal membrane traffic
van der Goot, F. G., & Gruenberg, J. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.08.003 · Cited by 197
Combating apoptosis and multidrug resistant cancers by targeting lysosomes
Groth-Pedersen, L., & Jäättelä, M. (2013) · Cancer Letters · doi:10.1016/j.canlet.2010.05.021 · Cited by 193
Self-citationSloane, B. F., Moin, K., Sameni, M., Tait, L. R., Rozhin, J., & Ziegler, G. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.2.373 · Cited by 185
Neuraminidase 1 Is a Negative Regulator of Lysosomal Exocytosis
Yogalingam, G., Bonten, E. J., van de Vlekkert, D., Hu, H., Moshiach, S., Connell, S. A., & d'Azzo, A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.005 · Cited by 185
Uemura, T., Shiozaki, K., Yamaguchi, K., Miyazaki, S., Satomi, S., Kato, K., Sakuraba, H., & Miyagi, T. (2009) · Oncogene · doi:10.1038/onc.2008.471 · Cited by 184
Abboud-Jarrous, G., Atzmon, R., Peretz, T., Palermo, C., Gadea, B. B., Joyce, J. A., & Vlodavsky, I. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801327200 · Cited by 181
Cathepsin L, target in cancer treatment?
Lankelma, J. M., Voorend, D. M., Barwari, T., Koetsveld, J., Van der Spek, A. H., De Porto, A. P. N. A., Van Rooijen, G., & Van Noorden, C. J. F. (2010) · Life Sciences · doi:10.1016/j.lfs.2009.11.016 · Cited by 180
Multiple Roles for Cysteine Cathepsins in Cancer
Joyce, J. A., & Hanahan, D. (2004) · Cell Cycle · doi:10.4161/cc.3.12.1289 · Cited by 173
Sevenich, L., Schurigt, U., Sachse, K., Gajda, M., Werner, F., Müller, S., Vasiljeva, O., Schwinde, A., Klemm, N., Deussing, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907240107 · Cited by 172
Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
Vlodavsky, I., Mohsen, M., Lider, O., Cm, S., Hp, E., Vigoda, M., Ishai-Michaeli, R., & Peretz, T. (1994) · PubMed · Cited by 170
Dumitru, C. A., & Gulbins, E. (2006) · Oncogene · doi:10.1038/sj.onc.1209568 · Cited by 163
Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases
Canals, D., Perry, D. M., Jenkins, R. W., & Hannun, Y. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01279.x · Cited by 162
Dredge, K., Hammond, E., Handley, P., Gonda, T. J., Smith, M. T., Vincent, C., Brandt, R., Ferro, V, & Bytheway, I. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.11 · Cited by 162
Cathepsin K mRNA and Protein Expression in Prostate Cancer Progression
Brubaker, K., Vessella, R., True, L., Thomas, R., & Corey, E. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.2.222 · Cited by 162
Liu, C., Lee, P., Lin, D., Wu, C.-C., Jeng, L., Lin, P.-W., Mok, K., Lee, W., Yeh, H., Ho, M., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.023 · Cited by 155
Molecular Regulation of Human Cathepsin B: Implication in Pathologies
Yan, S., & Sloane, B. F. (2003) · Biological Chemistry · doi:10.1515/bc.2003.095 · Cited by 153
The a 3 Isoform Vacuolar Type H+-ATPase Promotes Distant Metastasis in the Mouse B16 Melanoma Cells
Nishisho, T., Hata, K., Nakanishi, M., Morita, Y., Sun‐Wada, G., Wada, Y., Yasui, N., & Yoneda, T. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0449 · Cited by 151
Häntschel, M., Pfister, K., Jordan, A., Scholz, R., Andreesen, R., Schmitz, G., Schmetzer, H. M., Hiddemann, W., & Multhoff, G. (2000) · Cell Stress and Chaperones · Cited by 143
Procathepsin L Degrades Extracellular Matrix Proteins in the Presence of Glycosaminoglycans in Vitro
Ishidoh, K., & Kominami, E. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2820 · Cited by 139
Delivery of endocytosed membrane proteins to the lysosome
Pryor, P. R., & Luzio, J. P. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.12.022 · Cited by 136
Rafn, B., Nielsen, C. F., Andersen, S., Szyniarowski, P., Corcelle–Termeau, E., Valo, E., Fehrenbacher, N., Olsen, C. J., Daugaard, M., Egebjerg, C., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.01.029 · Cited by 134
Self-citationVasiljeva, O. S., & Turk, B. (2007) · Biochimie · doi:10.1016/j.biochi.2007.10.004 · Cited by 134
Low‐molecular‐weight heparins and angiogenesis
Norrby, K. (2006) · Apmis · doi:10.1111/j.1600-0463.2006.apm_235.x · Cited by 134
Ni, X., & Morales, C. R. (2006) · Traffic · doi:10.1111/j.1600-0854.2006.00429.x · Cited by 128
The cathepsin family and their role in colorectal cancer
Kuester, D., Lippert, H., Roessner, A., & Krueger, S. (2008) · Pathology - Research and Practice · doi:10.1016/j.prp.2008.04.010 · Cited by 126
Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategy
Spugnini, E. P., Citro, G., & Fais, S. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-44 · Cited by 124
Ceramide-induced cell death in malignant cells
Carpinteiro, A., Dumitru, C. A., Schenck, M., & Gulbins, E. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.020 · Cited by 122
Linke, T. A., Wilkening, G., Lansmann, S., Moczall, H., Bartelsen, O., Weisgerber, J., & Sandhoff, K. (2001) · Biological Chemistry · doi:10.1515/bc.2001.035 · Cited by 122
Reinheckel, T., Hagemann, S., Dollwet-Mack, S., Martinez, E., Lohmüller, T., Zlatkovic, G., Tobin, D. J., Maas‐Szabowski, N., & Peters, C. (2005) · Journal of Cell Science · doi:10.1242/jcs.02469 · Cited by 121
Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis
Dennemärker, J., Lohmüller, T., Mayerle, J. V., Tacke, M., Lerch, M. M., Coussens, L. M., Peters, C., & Reinheckel, T. (2009) · Oncogene · doi:10.1038/onc.2009.466 · Cited by 120
Matarrese, P., Ascione, B., Ciarlo, L., Vona, R., Leonetti, C., Scarsella, M., Mileo, A. M., Catricalà, C., Paggi, M. G., & Malorni, W. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-207 · Cited by 117
Vasiljeva, O. S., Korovin, M. S., Gajda, M. R., Brodoefel, H., Bojić, L., Krüger, A., Schurigt, U., Sevenich, L., Turk, B., Peters, C., et al. (2008) · Oncogene · doi:10.1038/onc.2008.59 · Cited by 115
Development of Heparanase Inhibitors for Anti-Cancer Therapy
Zhu, Z., Navarro, E. C., Kussie, P. H., et al. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706777935230 · Cited by 108
Mai, J., Sameni, M., Mikkelsen, T., & Sloane, B. F. (2002) · Biological Chemistry · doi:10.1515/bc.2002.159 · Cited by 102
Role for LAMP-2 in endosomal cholesterol transport
Schneede, A., Schmidt, C. K., Hölttä‐Vuori, M., Heeren, J., Willenborg, M., Blanz, J., Domanskyy, M., Breiden, B., Brodesser, S., Landgrebe, J., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00973.x · Cited by 98
Stefin B Interacts with Histones and Cathepsin L in the Nucleus
Čeru, S., Konjar, Š., Maher, K., Repnik, U., Križaj, I., Benčina, M., Renko, M., Nepveu, A., Žerovnik, E., Turk, B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.034793 · Cited by 98
Basche, M., Gustafson, D. L., Holden, S. N., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2423 · Cited by 97
Chloroquine-Induced Neuronal Cell Death Is p53 and Bcl-2 Family-Dependent But Caspase-Independent
Zaidi, A. U., McDonough, J. S., Klocke, B. J., Latham, C. B., Korsmeyer, S. J., Flavell, R. A., Schmidt, R. E., & Roth, K. A. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.10.937 · Cited by 95
Leto, G., Tumminello, F. M., Crescimanno, M., Flandina, C., & Gebbia, N. (2004) · Clinical & Experimental Metastasis · doi:10.1023/b:clin.0000024740.44602.b7 · Cited by 91
Sevenich, L., Werner, F., Gajda, M., Schurigt, U., Sieber, C., Müller, S., Follo, M., Peters, C., & Reinheckel, T. (2011) · Oncogene · doi:10.1038/onc.2010.387 · Cited by 85
Gocheva, V., Chen, X., Peters, C., Reinheckel, T., & Joyce, J. A. (2010) · Biological Chemistry · doi:10.1515/bc.2010.080 · Cited by 85
Cathepsin K in Melanoma Invasion
Quintanilla‐Dieck, M. J., Codriansky, K. A., Keady, M., Bhawan, J., & Rünger, T. M. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.63 · Cited by 84
Inhibition of heparanase activity and heparanase‐induced angiogenesis by suramin analogues
Marchetti, D., Reiland, J., Erwin, B., & Roy, M. (2003) · International Journal of Cancer · doi:10.1002/ijc.10930 · Cited by 84
Torigoe, T., Izumi, H., Ishiguchi, H., Uramoto, H., Murakami, T., Ise, T., Yoshida, Y., Tanabe, M., Nomoto, M., Itoh, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202605200 · Cited by 83
Aberrant expression of sialidase and cancer progression
Miyagi, T. (2008) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.84.407 · Cited by 78
Evidence for two mechanisms by which tumor necrosis factor kills cells
Reid, T. R., Torti, F. M., & RINGOLD, G. M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83783-8 · Cited by 77
Characterization of Mechanisms Involved in Secretion of Active Heparanase
Shafat, I., Vlodavsky, I., & Ilan, N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602762200 · Cited by 77
Sullivan, S., Tosetto, M., Kevans, D., Coss, A., Wang, L., O’Donoghue, D. P., Hyland, J. M., Sheahan, K. D., Mulcahy, H. E., & O'Sullivan, J. N. (2009) · International Journal of Cancer · doi:10.1002/ijc.24275 · Cited by 75
Membrane repair: Ca 2+ -elicited lysosomal exocytosis
Gerasimenko, J. V., Gerasimenko, O. V., & Petersen, O. H. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00577-2 · Cited by 74
Structural basis for the recognition and cleavage of histone H3 by cathepsin L
Adams-Cioaba, M. A., Krupa, J. C., Xu, C., Mort, J. S., & Min, J. (2011) · Nature Communications · doi:10.1038/ncomms1204 · Cited by 70
Beckham, T. H., Lu, P., Cheng, J., Zhao, D., Turner, L. S., Zhang, X., Hoffman, S., Armeson, K. E., Liu, A., Marrison, S. T., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27480 · Cited by 68
Loss of cathepsin L activity promotes claudin‐1 overexpression and intestinal neoplasia
Boudreau, F., Lussier, C. R., Mongrain, S., Darsigny, M., Drouin, J. L., Doyon, G., Suh, E. R., Beaulieu, J., Rivard, N., & Perreault, N. (2007) · The FASEB Journal · doi:10.1096/fj.07-8113com · Cited by 68
Recent developments in cathepsin K inhibitor design.
Grabowskal, U., Chambers, T. J., & Shiroo, M. (2005) · PubMed · Cited by 67
Pre-clinical and clinical significance of heparanase in Ewing’s sarcoma
Shafat, I., Ben‐Arush, M. W., Issakov, J., Meller, I., Naroditsky, I., Tortoreto, M., Cassinelli, G., Lanzi, C., Pisano, C., Ilan, N., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01190.x · Cited by 55
Rey, E. O., Martín, J. M. S., Barros, F., & García, A. G. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2007.02.011 · Cited by 49
Acid ceramidase 1 expression correlates with a better prognosis in ER-positive breast cancer
Ruckhäberle, E., Holtrich, U., Engels, K., Hanker, L., Gätje, R., Metzler, D., Karn, T., Kaufmann, M., & Rody, A. (2009) · Climacteric · doi:10.3109/13697130902939913 · Cited by 48
Cigarette smoke condensate increases cathepsin-mediated invasiveness of oral carcinoma cells
Nagathihalli, N. S., & Zacharias, W. (2007) · Toxicology Letters · doi:10.1016/j.toxlet.2007.02.014 · Cited by 46
Heparin, Heparan Sulfate and Heparanase in Cancer: Remedy for Metastasis?
Li, J. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008783330824 · Cited by 46
Schurigt, U., Sevenich, L., Vannier, C., Gajda, M. R., Schwinde, A., Werner, F., Stahl, A., von Elverfeldt, D., Becker, A.-K., Bogyo, M. S., et al. (2008) · Biological Chemistry · doi:10.1515/bc.2008.115 · Cited by 42
Omeprazole Induces Apoptosis in Jurkat Cells
Scaringi, L., Cornacchione, P., Ayroldi, E., Corazzi, L., Capodicasa, E., Rossi, R., & Marconi, P. (2004) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200401700313 · Cited by 41
Cathepsin L in metastatic bone disease: therapeutic implications
Leto, G., Sepporta, M. V., Crescimanno, M., Flandina, C., & Tumminello, F. M. (2010) · Biological Chemistry · doi:10.1515/bc.2010.069 · Cited by 32
Molecular facets of sphingolipids: Mediators of diseases
Özbayraktar, F. B. K., & Ülgen, K. Ö. (2009) · Biotechnology Journal · doi:10.1002/biot.200800322 · Cited by 32
Protective role of cathepsin L in mouse skin carcinogenesis
Benavides, F. J., Pérez, C. J., Blando, J. M., Contreras, O., Shen, J., Coussens, L. M., Fischer, S. M., Kusewitt, D. F., DiGiovanni, J., & Conti, C. J. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20792 · Cited by 30
Development of Cathepsin Inhibitors and Structure-Based Design of Cathepsin B-Specific Inhibitor
Tomoo, K. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610791113441 · Cited by 25
Walz, M., Kellermann, S., Bylaitė, M., Andrée, B., Rüther, U., Paus, R., Kloepper, J. E., REIFENBERGER, J., & Ruzicka, T. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00579.x · Cited by 21
Victor, B. C., & Sloane, B. F. (2007) · Biological Chemistry · doi:10.1515/bc.2007.150 · Cited by 20
Katunuma, N., Tsuge, H., Nukatsuka, M., & Fukushima, M. (2002) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(01)00060-7 · Cited by 16
Effect of procathepsin D activation peptide on gene expression of breast cancer cells
Beneš, P., Vashishta, A., Saraswat-Ohri, S., Fusek, M., Pospı́šilová, Š., Tichý, B., & Větvička, V. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.07.030 · Cited by 15
Cited by
The lysosome: from waste bag to potential therapeutic target
Appelqvist, H., Wäster, P., Kågedal, K., & Öllinger, K. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt022 · Cited by 772
Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response
Olson, O. C., & Joyce, J. A. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4027 · Cited by 699
Lysosomal cell death at a glance
Aits, S., & Jäättelä, M. (2013) · Journal of Cell Science · doi:10.1242/jcs.091181 · Cited by 667
Self-citationMechanisms and functions of lysosome positioning
Pu, J., Guardia, C. M., Keren-Kaplan, T., & Bonifacino, J. S. (2016) · Journal of Cell Science · doi:10.1242/jcs.196287 · Cited by 570
Lysosomes as mediators of drug resistance in cancer
Zhitomirsky, B., & Assaraf, Y. G. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2015.11.004 · Cited by 482
Metadata
- Authors
- Kallunki, T., Olsen, O. D., & Jäättelä, M.
- Venue
- Oncogene
- Published
- 2012-07-09
- Volume
- 32
- Issue
- 16
- Pages
- 1995-2004
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1545184254
- Cited by
- 298
- References
- 140
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.